The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Discovery and validation of a genomic signature to identify women with early-stage invasive breast cancer who may safely omit adjuvant radiotherapy after breast-conserving surgery.
 
Martin Sjöström
Research Funding - PFS Genomics (Inst); PFS Genomics (Inst)
 
S. Laura Chang
Employment - PFS Genomics
Leadership - PFS Genomics
Stock and Other Ownership Interests - PFS Genomics
Research Funding - PFS Genomics
Patents, Royalties, Other Intellectual Property - Co-inventor on patents pending with GenomeDx Biosciences in prostate cancer, unrelated to this work.; Co-inventor on patents pending with GenomeDx Biosciences in prostate cancer, unrelated to this work. (I); Co-inventor on provisional patents for PFS Genomics.
 
Linda Hartman
No Relationships to Disclose
 
Erik Holmberg
Patents, Royalties, Other Intellectual Property - Research contract with PFS genomics. IP regarding genomic profile.
 
Felix Y Feng
Leadership - PFS Genomics
Stock and Other Ownership Interests - PFS Genomics
Honoraria - Genentech
Consulting or Advisory Role - Astellas Pharma; Blue Earth Diagnostics; Celgene; Genentech; Janssen Biotech; Myovant Sciences; Roivant; SerImmune
Research Funding - Zenith Epigenetics
Patents, Royalties, Other Intellectual Property - I helped develop a molecular signature to predict radiation resistance in breast cancer, and this signature was patented by the University of Michigan, my employer. It is in the process of being licensed to PFS Genomics, a company that I helped found. (Inst)
 
Corey Wayne Speers
Stock and Other Ownership Interests - PFS Genomics
Patents, Royalties, Other Intellectual Property - Compositions and Methods for the Analysis of Radiosensitivity, UM-33550/US-1, Coinventor, Submitted on 09/2013; Methods and Genomic Classifiers for Prognosis of Breast Cancer and Predicting Benefit from Adjuvant Radiotherapy, Application No. 61/205,279, Co-inventor, Submitted on
(OPTIONAL) Uncompensated Relationships - PFS Genomics
 
Lori J. Pierce
Stock and Other Ownership Interests - PFS Genomics
Patents, Royalties, Other Intellectual Property - PFS Genomics; UpToDate
(OPTIONAL) Uncompensated Relationships - Bristol-Myers Squibb
 
Per Malmström
Patents, Royalties, Other Intellectual Property - PFS Genomics
 
Mårten Fernö
Honoraria - AstraZeneca; Novartis; Pfizer; Roche
Research Funding - PFS Genomics
Patents, Royalties, Other Intellectual Property - PFS Genomics
Travel, Accommodations, Expenses - AstraZeneca; Pfizer; Roche
 
Per Karlsson
Consulting or Advisory Role - Roche
Patents, Royalties, Other Intellectual Property - Contract with PFS genomics regarding of gen profile and intelectual property/royalties; Pending application of patent for a RT biomarker